David J. Rosa Sells 80,710 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) President David J. Rosa sold 80,710 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the sale, the president now directly owns 163,399 shares of the company’s stock, valued at approximately $63,607,962.72. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $388.22 on Friday. Intuitive Surgical, Inc. has a one year low of $222.65 and a one year high of $392.00. The company has a market cap of $136.78 billion, a price-to-earnings ratio of 77.18, a PEG ratio of 6.08 and a beta of 1.37. The firm has a 50 day simple moving average of $348.85 and a 200 day simple moving average of $314.02.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its quarterly earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The company had revenue of $1.93 billion during the quarter, compared to analysts’ expectations of $1.89 billion. During the same period in the prior year, the company earned $0.91 EPS. Intuitive Surgical’s revenue was up 16.6% compared to the same quarter last year. As a group, analysts expect that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Solstein Capital LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth $25,000. OFI Invest Asset Management acquired a new position in Intuitive Surgical during the 3rd quarter worth about $25,000. Baystate Wealth Management LLC increased its stake in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the period. MCF Advisors LLC raised its position in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the last quarter. Finally, RFP Financial Group LLC lifted its stake in shares of Intuitive Surgical by 166.7% in the second quarter. RFP Financial Group LLC now owns 80 shares of the medical equipment provider’s stock worth $27,000 after acquiring an additional 50 shares during the period. Institutional investors own 82.91% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on ISRG. Stifel Nicolaus upped their target price on Intuitive Surgical from $360.00 to $420.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Mizuho lifted their target price on Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research note on Friday, January 19th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Finally, SVB Leerink assumed coverage on shares of Intuitive Surgical in a research report on Monday, October 16th. They set an “outperform” rating and a $342.00 target price on the stock. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $371.60.

Check Out Our Latest Report on Intuitive Surgical

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.